The 12th meeting on Genome Medicine hosted by the National Human Genome Research Institute focused on Genomics and Risk Prediction in Silver Spring, MD. Dr. Tatonetti speaks to the group about how to use commonly collected hospital data to infer millions of familial relationships between patients and use this novel resource to study disease heritability, […]
The Tatonetti Lab’s work is featured in the latest issue of Nature Medicine in “Calculated Risk” by Nature staff writer, Shraddha Chakradhar. Read about the moment of discovery that propelled the lab into the field of drug safety, pharmacovigilance, and drug-drug interactions here.
ABC (Austrialian Broadcasting Company) interviews Dr. Tatonetti for their Health Report podcast. We talk data science, electronic health records, and the importance of maintaining patient privacy when conducting large scale analyses. Click to listen.
On the cover: Vast amounts of medical records are stored in hospitals and clinics around the world. Digitalization of these records has made them available for secondary use in research of human disease and treatment. In this issue of Cell, Polubriaginof et al. (1692-1704) use these records to study disease heritability. The cover image is […]
In this commentary Dr. Tatonetti argues for a different approach for monitoring drug safety in the marketplace that combines data from spontaneous reporting systems in humans with experiments in models systems. This approach has the speed and agility of observational research with the rigor and robustness of prospective trials. Read the whole commentary here.